
Alnylam Pharmaceuticals, Inc.
ALNYNASDAQ
USReal-Time Price
$156.86USD
+0.92 (+0.59%)Today
Investors Sentoments
Sign in to share your view.
BTI Score
BASIC required or higher
View pricingBTI Fair Market Cap
$41.04B
-48.81% vs fair
Biotechnology
Strong Buy
Alnylam Pharmaceuticals, Inc. (ALNY) Key Statistics
All Alnylam Pharmaceuticals, Inc. (ALNY) key statistics in one place: market cap, valuation multiples, profitability, growth and risk metrics.
Valuation Measures
Market Cap$21.01B
Enterprise Value$20.52B
Trailing P/E7.67
Forward P/E25.62
PEG Ratio—
Price / Sales (TTM)—
Price / Book—
EV / Revenue4.09
EV / EBITDA—
Financial Highlights
Fiscal Year End—
Most Recent Quarter—
Profit Margin—
Operating Margin—
Return on Assets—
Return on Equity—
Quarterly Rev. Growth—
Gross Profit—
EBITDA—
Net Income—
Diluted EPS$19.80
Total Cash—
Total Debt—
Free Cash Flow—
Trading Information
Beta (5Y Monthly)0.47
52-Week Change—
S&P 500 52-Wk Change—
52-Week High$479.79
52-Week Low$152.17
50-Day MA—
200-Day MA—
Avg. Volume2.00M
Shares Outstanding875.2M
Float815.4M
Short % of Float—
Short Ratio—


